Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3507 Target Snapshot

Mineralocorticoid receptor · SINGLE PROTEIN · Rattus norvegicus

282Compounds
108Assays
2Approved Drugs
102.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P22199. Use UniProt P22199 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P22199 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Mineralocorticoid receptor as ChEMBL target CHEMBL3507, mapped to UniProt P22199. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Mineralocorticoid receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3507
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P22199
Mineralocorticoid receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Mineralocorticoid receptor is the right protein anchor across sources, using UniProt P22199 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMineralocorticoid receptor
UniProt AccessionP22199
Component TypeProtein
Sequence Length981 aa

Mineralocorticoid receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Mineralocorticoid receptor, mapped to UniProt P22199. Sequence length is 981 aa.

Mapped IDP22199
Review nameMineralocorticoid receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
3
Phase II
Assay Mix

Activity Type Distribution

IC5079.0
KI23.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2181928 8.49 IC50 3.2 Preclinical
CHEMBL4532472 8.1 IC50 7.943 Preclinical
CHEMBL4540313 8.0 IC50 10.0 Preclinical
CHEMBL2181930 7.68 IC50 21.0 Preclinical
CHEMBL2181931 7.66 IC50 22.0 Preclinical
CHEMBL4087750 7.66 IC50 22.0 Preclinical
CHEMBL2181929 7.51 Ki 30.8 Clinical
CHEMBL4085281 7.51 IC50 31.0 Preclinical
CHEMBL1095097 7.4 IC50 39.81 Approved
CHEMBL273453 7.37 IC50 43.0 Clinical
Distribution

pChEMBL Value Distribution

9
5.0
9
5.5
8
6.0
2
6.5
12
7.0
6
7.5
3
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

EPLERENONE
CHEMBL1095097
Approved 2002
Assay Landscape

Assay Landscape

108
Total Assays
52
Tested Compounds
3
Assay Types
Functional — 65 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 31 0
organism-based format 24 0
assay format 10 0
Binding — 42 assays, 52 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 33 28 6.1
assay format 5 7 7.3
cell-based format 4 17 6.4
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine